Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
説明 | GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury. |
別名 | GSK 329, GSK-329 |
分子量 | 472.25 |
分子式 | C19H14Cl2F3N5O2 |
CAS No. | 1268490-12-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (518.79 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK329 1268490-12-5 Others GSK 329 diarylurea cardiac-specific kinase cardioprotective outcomes inhibit Inhibitor ischemia/reperfusion GSK-329 TNNI3K inhibitor